Home - Prescription Medicines - Haichang® | Ambroxol Hydrochloride Solution for Inhalation | Respiratory Tract Diseases | DengYueRX
Description
Indication & Scope
A single-dose inhalation solution containing ambroxol hydrochloride, a mucoactive respiratory medicine used to facilitate clearance of thick bronchial secretions. The product is supplied in brown glass ampoules and is intended for administration using a nebulizer; it is not for oral or injectable use.
- Mechanism:
Ambroxol promotes mucociliary clearance by modifying airway secretions, stimulating surfactant secretion and enhancing ciliary activity. These effects help reduce mucus viscosity/adhesion and facilitate movement and expectoration of bronchial mucus. The precise mechanism is not completely established. - Drug class:
Mucoactive agent / mucolytic and secretolytic expectorant; ATC R05CB06 (Ambroxol). - Clinical use:
Adjunctive symptomatic treatment of respiratory conditions characterized by thick or difficult-to-expectorate secretions, particularly acute and chronic bronchitis and pneumonia.
| Generic Name | Ambroxol Hydrochloride Solution for Inhalation |
|---|---|
| Brand Name | Haichang |
| Ingredient | Ambroxol hydrochloride |
| Dosage Form | Inhalation solution |
| Package | Brown neutral-borosilicate glass ampoules, 2 mL/ampoule × 6 ampoules/box |
| Conditions Treated | Acute/chronic respiratory diseases with viscous mucus and difficulty expectorating, including acute/chronic bronchitis and pneumonia |
| Taboos | Contraindicated in patients allergic to ambroxol hydrochloride or any component of the product |
| Place of origin | China |
| Prescription type | Prescription medicine |
| Storage Conditions | Protect from light; keep tightly closed; store at ≤25°C |
| Manufacturer | Yunnan Longhai Natural Plant Pharmaceutical Co., Ltd. |
| Registration Authority | National Medical Products Administration (NMPA), China |
| Approval Number | H20203668 |
| Approval Date | 11 December 2020 |
| Shelf Life | 24 months |
How to use ?
Recommended Dose:
- Adults and children ≥12 years: 2–3 mL per administration, inhaled 1–2 times daily; equivalent to 15–45 mg/day.
- Children 2–12 years: 2 mL per administration, inhaled 1–2 times daily; 15–30 mg/day.
- Children 6 months–2 years: 1 mL per administration, inhaled 1–2 times daily; 7.5–15 mg/day.
- The manufacturer’s recommended treatment period is 7 days, with duration adjustable according to the patient’s symptoms and physician advice.
Time: 1–2 inhalation treatments per day, according to the age-specific dose above.
Instructions for use:
- Use only with a nebulizer; do not swallow or inject.
- The manufacturer instructs that the solution should be mixed 1:1 with 0.9% sodium chloride injection for optimal humidification.
- Open a new single-dose ampoule immediately before each treatment. The product contains no preservative. Discard partially used, opened or damaged ampoules.
- Place the prescribed amount in the nebulizer and administer according to the nebulizer manufacturer’s instructions.
- After treatment, discard remaining solution and clean the nebulizer.
Interaction: The product may be mixed with β-sympathomimetic medicines and inhaled ipratropium bromide solution according to the manufacturer’s instructions, but should not be mixed with sodium cromoglycate. Avoid mixing with medicines that raise the resulting solution’s pH above 6.3. Concomitant antitussives should be considered carefully because suppression of the cough reflex can increase the risk of retained secretions. Ambroxol may increase concentrations of some antibiotics in bronchopulmonary secretions, including erythromycin, cefalexin, tetracycline, amoxicillin, cefuroxime and doxycycline.
Side effects:
- Common: taste disturbance, nausea, oral/throat numbness.
- Uncommon: vomiting, diarrhea, dyspepsia, abdominal pain, dry mouth, fever and mucosal reactions.
- Rare: hypersensitivity, rash, urticaria, dry throat and dysuria.
- Very rare/unknown: dyspnea, bronchospasm and severe cutaneous reactions, including Stevens–Johnson syndrome/toxic epidermal necrolysis and AGEP.
Important Notice
This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indication, and regional regulatory requirements.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What is Haichang inhalation solution used for?
It contains ambroxol hydrochloride and is used to facilitate the clearance of thick respiratory mucus in conditions such as acute/chronic bronchitis and pneumonia.
Can Haichang be taken orally?
No. This particular formulation is specifically an inhalation solution for use with a nebulizer and should not be swallowed or injected.
Can children use Ambroxol Hydrochloride Solution for Inhalation?
The manufacturer’s labeling provides doses for children from 6 months of age, with age-specific dosing. There are no established safety/efficacy data in children below 6 months in this product information.
How should the ampoules be stored?
Store protected from light, tightly closed and at no more than 25°C. The stated shelf life is 24 months.
Haichang® | Ambroxol Hydrochloride Solution for Inhalation | Respiratory Tract Diseases | DengYueRX
INN: Ambroxol hydrochloride (Ambroxol)
Indications: Acute and chronic respiratory diseases, including acute/chronic bronchitis and pneumonia, associated with viscous mucus and difficulty expectorating.
Dosage Form: Inhalation solution / nebulizer solution
Strength: 2 mL: 15 mg
$6.05 Original price was: $6.05.$5.14Current price is: $5.14.